ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AstraZeneca's head and neck cancer treatment Imfinzi falls flat in Phase III trials
December 10, 2018AstraZeneca’s immunotherapy treatment Imfinzi has failed to meet its primary goal in treating head and neck cancer in the Phase III EAGLE trial. -
First-line Keytruda shows better overall survival in head & neck cancer
November 01, 2018MSD’s Keytruda (pembrolizumab) made an impact at the European Society for Medical Oncology 2018 Congress as the company unveiled new Phase 3 data into its efficacy in the first-line treatment... -
MSD’s Keytruda hits rare snag, floundering in confirmatory trial
July 26, 2017Since the PD-1/PD-L1 immunotherapies have hit the market, they have revolutionised cancer care for many patients yet, with the science not completely understood
Pharma Sources Insight January 2025
